GlassScriptPhysician profile
Michele Ann Barts
NPI 1477248409
$936.61
in general payments reported to CMS, 2019-2025
16 companies · $186 in 2025
The $186 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $42.93 · 2024: $708 · 2025: $186.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $937.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $936.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $264.51 | 2024-2025 | |
| Janssen Pharmaceuticals, INC | $151.52 | 2024 | Xarelto |
| Merck Sharp & Dohme LLC | $105.73 | 2024-2025 | Verquvo |
| E.R. Squibb & Sons, L.L.C. | $53.88 | 2025 | Camzyos, Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $48.83 | 2024 | Lifevest |
| Scpharmaceuticals INC. | $48.19 | 2023-2025 | |
| Kiniksa Pharmaceuticals International, Plc | $45.04 | 2024 | Arcalyst |
| Boston Scientific Corporation | $35.60 | 2024 | Wavewriter Alpha Prime 16 |
| Bayer Healthcare Pharmaceuticals INC. | $35.44 | 2024-2025 | |
| Novo Nordisk INC | $32.01 | 2024 | Ozempic, Rybelsus |
| Lexicon Pharmaceuticals, INC. | $28.89 | 2023-2024 | Inpefa |
| Sanofi-Aventis U.S. LLC | $21.33 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $18.00 | 2024 | Evkeeza |
| Amgen INC. | $16.69 | 2024 | Repatha |
| Irhythm Technologies, INC. | $15.56 | 2024 | Zio Xt Patch, Zio Monitor |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $15.39 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michele Barts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.